Advertisement

The Lead

Bristol-Myers Squibb Sells OTC Assets in Asia Pacific to Taisho Pharmaceutical Co Ltd.

September 16, 2009 4:27 am | News | Comments

Bristol-Myers Squibb Company has reached an agreement for the sale of its OTC assets in Asia Pacific (excluding China and Japan) to Taisho Pharmaceutical Co., Ltd. (“Taisho”).

View Sample

FREE Email Newsletter

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading